Japan stock market week to Feb 9, 2009

16 February 2009

Tokyo extended its gain for a second week, following mixed moves in the review week to February 9. The Nikkei 225 rose 1.2%, although it still  finished below the psychologically-important 8,000 mark, while the Topix  index inched up 0.1%. The market was strong mid-week, reflecting  Japanese investors' purchasing of machinery, shipbuilding and steel  stocks in anticipation of a recovery in the Chinese economy. The last  two sessions saw a downturn due to profit-taking of the China-related  issues and players resumed focusing on Japanese companies' dismal  third-quarter earnings and increasingly uncertain outlook for the full  year to March 2009. The pharmaceutical index lost 3.0%, underperforming  the market.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Company News Directory



Companies featured in this story

More ones to watch >






Company Spotlight